coronavirus

Excerpts: a Sunday note from Morgan Stanley’s chief biotech analyst Matthew Harrison Welcome to your first and only chance to have a Morgan Stanley biotech analyst tell you what he thinks about the market. Over the past week it has been striking to see how investors have reacted to the first signs that new COVID-19 […]

Read More »

Excepts: “Billionaire Cliff Asness’ hedge fund AQR hit with $43B COVID-19 losses” The firm’s Multi-Strategy Alternative fund, for example, is down 22 percent this year following declines of 10 percent in 2019. Its Small-Cap Multi-Style fund, which was up 20 percent last year, is now down 29 percent. “That’s pretty terrible,” one hedge fund manager

Read More »

Excerpts: “Markets Infected by Coronavirus” Bonds are comfortably below 2 percent and the 10-year Treasury yield is hovering around 1.3 percent. Unlikely as it may seem, technical analysis now indicates a target yield on the 30-year bond at 1 percent and the 10-year note at 0.25 percent. Stocks are nearing correction territory, with more downside

Read More »